Person-specific factors that affect choice of treatment include individualized glycemic goals (see section 6, Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises), individualized weight goals (see section 8, Obesity and Weight Management for the Prevention and Treatment of Diabetes), the individuals risk for hypoglycemia, and the individuals history of or risk factors for cardiovascular, kidney, liver, and other comorbidities and complications of diabetes (see section 4, Comprehensive Medical Evaluation and Assessment of Comorbidities, section 10, Cardiovascular Disease and Risk Management, and section 11, Chronic Kidney Disease and Risk Management)
Oxidative stress, which occurs as an outcome of lipid peroxidation, concurrently may have a key importance in the phase of carcinogenesis occurring with a multistage course devoted to environmental toxicity and in cancer pathogenesis
The comprehensive program is built to support your entire journey
Upper endoscopy (eophagogastroduodenoscopy or EGD)
Scientific Evidence Supporting GLP-1 Medications for Heart Health Multiple large-scale studies have reinforced the cardiovascular benefits of GLP-1 receptor agonists
